|
Name |
3-Ethylacetophenone
|
| Molecular Formula | C10H12O | |
| IUPAC Name* |
1-(3-ethylphenyl)ethanone
|
|
| SMILES |
CCC1=CC(=CC=C1)C(=O)C
|
|
| InChI |
InChI=1S/C10H12O/c1-3-9-5-4-6-10(7-9)8(2)11/h4-7H,3H2,1-2H3
|
|
| InChIKey |
ZRYRILAFFDKOPB-UHFFFAOYSA-N
|
|
| Synonyms |
3-ETHYLACETOPHENONE; 22699-70-3; 1-(3-Ethylphenyl)ethanone; m-Ethylacetophenone; 1-(3-Ethylphenyl)ethan-1-one; 3'-ETHYLACETOPHENONE; Acetophenone, 3-ethyl-; Ethanone,1-(3-ethylphenyl)-; Ethanone, 1-(3-ethylphenyl)-; methylacetophenon; m-Acetyl ethyl benzene; SCHEMBL334537; DTXSID20177223; ZINC2015440; BBL102901; CL9636; MFCD00009660; STL556710; AKOS006228241; PS-5477; DB-045969; CS-0207257; FT-0605623; EN300-1827755; 699E703; A816315
|
|
| CAS | 22699-70-3 | |
| PubChem CID | 31493 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 148.2 | ALogp: | 2.4 |
| HBD: | 0 | HBA: | 1 |
| Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 17.1 | Aromatic Rings: | 1 |
| Heavy Atoms: | 11 | QED Weighted: | 0.588 |
| Caco-2 Permeability: | -4.316 | MDCK Permeability: | 0.00002220 |
| Pgp-inhibitor: | 0.01 | Pgp-substrate: | 0.002 |
| Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.004 |
| 30% Bioavailability (F30%): | 0.075 |
| Blood-Brain-Barrier Penetration (BBB): | 0.79 | Plasma Protein Binding (PPB): | 86.87% |
| Volume Distribution (VD): | 0.449 | Fu: | 15.29% |
| CYP1A2-inhibitor: | 0.982 | CYP1A2-substrate: | 0.908 |
| CYP2C19-inhibitor: | 0.91 | CYP2C19-substrate: | 0.243 |
| CYP2C9-inhibitor: | 0.532 | CYP2C9-substrate: | 0.463 |
| CYP2D6-inhibitor: | 0.293 | CYP2D6-substrate: | 0.344 |
| CYP3A4-inhibitor: | 0.068 | CYP3A4-substrate: | 0.269 |
| Clearance (CL): | 5.638 | Half-life (T1/2): | 0.809 |
| hERG Blockers: | 0.068 | Human Hepatotoxicity (H-HT): | 0.043 |
| Drug-inuced Liver Injury (DILI): | 0.596 | AMES Toxicity: | 0.018 |
| Rat Oral Acute Toxicity: | 0.034 | Maximum Recommended Daily Dose: | 0.023 |
| Skin Sensitization: | 0.223 | Carcinogencity: | 0.171 |
| Eye Corrosion: | 0.833 | Eye Irritation: | 0.992 |
| Respiratory Toxicity: | 0.046 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC000413 | ![]() |
0.571 | D0X4ZR | ![]() |
0.333 | ||
| ENC000192 | ![]() |
0.447 | D0S5LH | ![]() |
0.319 | ||
| ENC003374 | ![]() |
0.404 | D0B7OD | ![]() |
0.315 | ||
| ENC000201 | ![]() |
0.395 | D0Q8ZX | ![]() |
0.313 | ||
| ENC000370 | ![]() |
0.395 | D02JIS | ![]() |
0.313 | ||
| ENC000203 | ![]() |
0.395 | D0X9RY | ![]() |
0.310 | ||
| ENC001049 | ![]() |
0.390 | D0WY5Q | ![]() |
0.300 | ||
| ENC000200 | ![]() |
0.390 | D0T3NY | ![]() |
0.291 | ||
| ENC000478 | ![]() |
0.383 | D06EQP | ![]() |
0.288 | ||
| ENC000218 | ![]() |
0.381 | D08USJ | ![]() |
0.286 | ||